MYX as a company now represents far less risk than it did before...

MYX as a company now represents far less risk than it did before the Teva deal  because of the diversity and number of products in its range. Don’t forget this deal had over 50 separate companies wanting in, but was given to Maynes after its due diligence and  had to prove they had the capabilities and manufacturing facilities to get FTC approval in Washington.

Because Maynes  now manufacture and distribute their products gives them far more control over the total business which in time will give them stronger sales growth and better profitability.

MYX is defiantly a growth stock of the future even though it has performed extremely well over the last 3 years where the management team has taking it from a $50M MC to over a $3 Billion company,  but I believe the best is yet to come as they have many products still under FDA approval  as well as other bolt on acquisitions.

Cheers Matsim